Published in TB and Outbreaks Week, October 22nd, 2002
Natural products have historically been a very rich source of antimicrobials and are estimated to be the source of over 90% of currently approved antimicrobial drugs.
Under the risk-sharing agreement, Elitra will contribute an unspecified number of proprietary drug targets and related cell-based assays and high throughput screening...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.